• Dermovate indications
• Uses of Dermovate in details
• Dermovate description
• Dermovate dosage
• Dermovate interactions
• Dermovate side effects
• Dermovate contraindications

What is Dermovate?

Dermovate lotion is a prescription corticosteroid medicine used on the skin (topical) for the relief of swelling (inflammation) and itching caused by certain skin conditions in people 18 years of age and older.

Dermovate lotion should not be used for the treatment of acne vulgaris, rosacea or red, dry itchy skin (dermatitis) around the mouth.

Dermovate lotion is not recommended in children under 18 years of age.

Important: Dermovate lotion is for use on the skin only. Do not get the lotion near or in your eyes, mouth or vagina.

Dermovate indications

Indication

Dermovate® Spray, 0.05% is a super-high potent topical corticosteroid formulation indicated for the treatment of moderate to severe plaque psoriasis affecting up to 20% body surface area (BSA) in patients 18 years of age or older. The total dosage should not exceed 50 g (59 mL or 2 fl. oz.) per week. Do not use more than 26 sprays per application or 52 sprays per day. Treatment should be limited to 4 consecutive weeks.

Patients should be instructed to use Dermovate® Spray, 0.05% for the minimum amount of time necessary to achieve the desired results see [Dosage and Administration (2)].

Use in patients under 18 years of age is not recommended because safety has not been established and because numerically high rates of HPA axis suppression were seen with other Dermovate topical formulations.

Limitations of Use

Dermovate® Spray, 0.05% should not be used on the face, axillae, or groin. Dermovate® Spray, 0.05% should not be used if there is atrophy at the treatment site. Dermovate® Spray, 0.05% should not be used in the treatment of rosacea or perioral dermatitis.

How should I use Dermovate?

Use Dermovate as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Wash your hands before using Dermovate. If your fingers are warm, rinse them in cold water and dry before you apply Dermovate.
• Use the smallest amount of medicine necessary to cover the affected area.
• Turn the can upside down and squirt a small amount of foam (up to the size of a golf ball or about 1½ capfuls) into the cap of the can, onto a clean saucer, or onto another cool, clean surface. You may also squirt it directly onto the affected area. Do not squirt the medicine directly into the hand because it will start to melt immediately upon touching warm skin.
• If you are applying Dermovate to the scalp, move the hair away from the affected area and gently rub the medicine into the affected area until the foam disappears. Repeat until the entire affected area of the scalp is treated.
• If you are applying Dermovate to other areas, gently rub the medicine into the skin until it disappears.
• Throw away any unused medicine that has been squirted out of the can.
• Wash your hands immediately after using Dermovate, unless your hands are a part of the treated area.
• Do not use Dermovate on your face, groin, or underarms unless your doctor tells you otherwise.
• Do not use Dermovate over large areas of the body without first checking with your doctor.
• Do not bandage or wrap the affected area unless directed to do so by your doctor.
• If the can seems warm or the foam seems runny, rinse the can with cool water.
• If you miss a dose of Dermovate, apply it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Dermovate.

Uses of Dermovate in details

Dermovate is used to treat itching, redness, dryness, inflammation, and discomfort of various scalp and skin conditions, including immune-mediated skin disease with red scaly patches (psoriasis).

Dermovate description

Dermovate scalp application also contains the following excipients: Carbomer, isopropyl alcohol, sodium hydroxide and purified water.

Dermovate cream also contains the following excipients: Glyceryl monostearate, cetostearyl alcohol, chlorocresol, sodium citrate, monohydrated citric acid, purified water, Arlacel 165, beeswax substitute 6621 and propylene glycol.

Dermovate ointment also contains the following excipients: Propylene glycol, white soft paraffin and sorbitan sesquioleate.

Dermovate dosage

Dermovate Dosage

Generic name: Dermovate 0.5mg in 1g

Dosage form: cream, ointment

See also:

• Dermovate Cream cream
• Dermovate E Cream cream
• Dermovate Gel topical gel

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

Apply a thin layer of Dermovate® Cream or Ointment to the affected skin areas twice daily and rub in gently and completely.

Dermovate® Cream and Ointment are super-high potency topical corti-costeroids; therefore, treatment should be limited to 2 consecutive weeks and amounts greater than 50 g/week should not be used.

As with other highly active corticosteroids, therapy should be discontinued when control has been achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary.

Dermovate® Cream and Ointment should not be used with occlusive dressings.

Geriatric Use: In studies where geriatric patients (65 years of age or older, see PRECAUTIONS) have been treated with Dermovate® Cream or Ointment, safety did not differ from that in younger patients; therefore, no dosage adjustment is recommended.

More about Dermovate (Dermovate)

• Side Effects
• During Pregnancy or Breastfeeding
• Dosage Information
• Drug Interactions
• Support Group
• Pricing & Coupons
• En Espanol
• 3 Reviews - Add your own review/rating

Consumer resources

• Dermovate cream
• Dermovate gel
• Dermovate solution
• Dermovate
• Dermovate (Advanced Reading)

• Other brands: Dermovate, Olux, Dermovate, Dermovate, More (7) »

Professional resources

• Dermovate (FDA)
• More (3) »

Other formulations

• Dermovate E

Related treatment guides

• Dermatological Disorders
• Lichen Planus
• Atopic Dermatitis
• Dermatitis
• Eczema
• More (2) »

Dermovate interactions

See also:
What other drugs will affect Dermovate?

Aldesleukin: Corticosteroids may diminish the antineoplastic effect of Aldesleukin. Avoid combination

Corticorelin: Corticosteroids may diminish the therapeutic effect of Corticorelin. Specifically, the plasma ACTH response to corticorelin may be blunted by recent or current corticosteroid therapy. Monitor therapy

Deferasirox: Corticosteroids may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased. Monitor therapy

Hyaluronidase: Corticosteroids may diminish the therapeutic effect of Hyaluronidase. Management: Patients receiving corticosteroids (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase. Larger doses of hyaluronidase may be required. Consider therapy modification

Ritodrine: Corticosteroids may enhance the adverse/toxic effect of Ritodrine. Monitor therapy

Dermovate side effects

See also:
What are the possible side effects of Dermovate?

Clinical Trials Experience

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug, and may not reflect the rates observed in practice.

Dermovate Cream was evaluated in two randomized, multicenter, prospective, vehicle-controlled clinical trials in subjects with moderate to severe plaque psoriasis. Subjects applied Dermovate Cream or vehicle cream twice daily for 14 days. A total of 354 subjects applied Dermovate Cream and 178 subjects applied vehicle.

The adverse reaction that occurred in at least 1% of subjects treated with Dermovate Cream and at a higher incidence than in subjects treated with vehicle cream was application site discoloration (2% versus 1%).

Less common local adverse events occurring in < 1% of subjects treated with Dermovate Cream were application site atrophy, telangiectasia and rash.

Postmarketing Experience

The following adverse reactions have been identified during post-approval use of Dermovate: striae, irritation, dryness, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, hypertrichosis, and miliaria. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

Dermovate contraindications

See also:
What is the most important information I should know about Dermovate?

Hypersensitivity to Dermovate or to any of the excipients of Dermovate.

Scalp Application: Infections of the scalp.

Cream/Ointment: Primary skin lesions caused by infection with fungi or bacteria; primary cutaneous viral infections (eg, herpes simplex, chickenpox); rosacea; acne vulgaris; pruritus without inflammation; perianal and genital pruritus; perioral dermatitis.

Use in children: Dermovate is contraindicated in children <1 year.

Children are more likely to develop local and systemic side effects of topical corticosteroids and in general, require shorter courses and less potent agents than adults.

Care should be taken when using Dermovate to ensure the amount applied is the minimum that provides therapeutic benefit.

Active ingredient matches for Dermovate:

Clobetasol topical in Antigua & Barbuda, Aruba, Austria, Bahamas, Bahrain, Bangladesh, Barbados, Belgium, Bermuda, Bosnia & Herzegowina, Bulgaria, Canada, Cayman Islands, Chile, Colombia, Costa Rica, Czech Republic, Dominican Republic, Ecuador, El Salvador, Estonia, Ethiopia, Georgia, Grenada, Guatemala, Guyana, Honduras, Hong Kong, Hungary, Indonesia, Iran, Ireland, Israel, Jamaica, Japan, Kuwait, Latvia, Lithuania, Luxembourg, Malaysia, Malta, Netherlands, Netherlands Antilles, Nicaragua, Oman, Panama, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russian Federation, Saint Lucia, Singapore, South Africa, Sri Lanka, Switzerland, Taiwan, Thailand, Trinidad & Tobago, Turkey, United Arab Emirates, United Kingdom, Venezuela, Vietnam.

Betamethasone in Brazil.

Clobetasol in Antigua & Barbuda, Aruba, Austria, Bahamas, Bahrain, Bangladesh, Barbados, Belgium, Bermuda, Bosnia & Herzegowina, Bulgaria, Canada, Cayman Islands, Chile, China, Colombia, Czech Republic, Estonia, Ethiopia, Georgia, Grenada, Guyana, Hong Kong, Hungary, Indonesia, Ireland, Israel, Jamaica, Japan, Latvia, Lithuania, Malaysia, Malta, Netherlands, Oman, Peru, Philippines, Poland, Romania, Russian Federation, Saint Lucia, Singapore, South Africa, South Korea, Switzerland, Taiwan, Thailand, Trinidad & Tobago, Turkey, United Kingdom, Venezuela, Vietnam.

Clobetasol propionate in United Kingdom, Ireland, Netherlands, Switzerland, Belgium, Austria, Hong Kong, Israel, Thailand, Singapore, Malaysia, Chile, Hungary, Czech Republic, Poland, Philippines, Russia, Indonesia, Venezuela, Turkey.

References

1. DailyMed. "CLOBETASOL PROPIONATE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
2. DailyMed. "BETAMETHASONE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
3. PubChem. "betamethasone". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).

Reviews

User reports

Consumer reviews

Information checked by Dr. Sachin Kumar, MD Pharmacology